Is Moderna's Stock Still Cheap?

Moderna Inc traded higher Thursday after the company announced it's developing a single-dose vaccine that combines a booster against COVID-19 and a booster against flu during its R&D Day.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.